Financial Architects, Inc Intellipharmaceutics International Inc. Transaction History

Financial Architects, Inc

  • $657 Million
  • Q2 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 03, 2019
SELL
$0.17 - $0.39 $34 - $78
-200 Closed
0 $0
Q3 2018

Oct 29, 2018
BUY
$2.4 - $5.3 $480 - $1,060
200 New
200 $1,000

About Intellipharmaceutics International Inc.

IPCIF Quotes by TradingView
  • Ticker IPCIF
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,092,700
  • Market Cap $4.96M
  • Description
  • Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in...
More about IPCIF
Track This Portfolio

Track Financial Architects, Inc Portfolio

Follow Financial Architects, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email